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ABSTRACT 
 
Background 
Primary radical radiotherapy (RT) for head and neck cancer (HNC) often results in significant 
radiation dose to the carotid arteries.    
 
Aim 
We assessed whether HNC patients are at increased risk of a cerebrovascular event 
primarily due to RT or other risk factors for atherosclerosis by: (i) risk-stratifying patients 
according to validated QRISK-2 and QSTROKE scores, (ii) comparing the prevalence of 
carotid artery stenosis (CAS) in irradiated and unirradiated carotid arteries. 
 
Design 
HNC patients treated with a radiotherapy dose greater than 50 Gy to one side of the neck ≥2 
years previously were included.    
 
Methods 
QRISK-2 (2014) and Q-STROKE (2014) scores were calculated.  We compared the 
prevalence of CAS in segments of the common carotid artery (CCA) on the irradiated and 
unirradiated sides of the neck.  
 
Results 
50 patients (median age of 58 yrs (interquartile range (IQR) 50 – 62)) were included.  The 
median QRISK-2 score was 10% (IQR 4.4-15%) and the median QSTROKE score was 
3.4% (IQR 1.4-5.3%).  For both scores, no patient was classified as high-risk. Thirty-eight 
patients (76%) had CAS in one or both arteries.  There was a significant difference in the 
number of irradiated arteries with stenosis (N=37) compared to unirradiated arteries (N=16) 
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(p<0.0001).  There were more plaques on the irradiated artery compared to the unirradiated 
side (64/87) (73.6%) versus 23/87 (26.4%), respectively) (p<0.001).  
 
Conclusions 
 
Traditional vascular risk factors do not play a role in radiation-induced carotid 
atherosclerosis.   Clinicians should be aware that traditional risk prediction models may 
under-estimate stroke risk in these patients.   
 
 
Keywords: radiotherapy, atherosclerosis, carotid stenosis, Q-STROKE, Q-RISK2 
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BACKGROUND 
 
Primary radical radiotherapy (RT) for head and neck cancer often results in significant 
incidental doses of radiation to the carotid arteries. For patients requiring lymph node 
irradiation, the treatment fields will extend from the mastoid process superiorly down to just 
below the clavicles inferiorly.  Therefore, in this scenario, the common, internal, and external 
carotid arteries (and some of their branches) will receive full radiation dose as lymph nodes 
are located in close proximity to the vessels (Figure 1).   Carotid artery stenosis (CAS) is a 
risk factor for subsequent neurological sequelae. 1-3  Radiotherapy to the cervical vessels is 
associated with increased CAS 4-6 and increased incidence of stroke. 7  
 
Several factors are associated with increased stroke risk: increasing age, smoking, diabetes 
mellitus, hypertension, hypercholesterolaemia, obesity and radiotherapy (RT) to the affected 
vessels.8  Patients with head and neck cancer may have one or more risk factors associated 
with stroke risk, as smoking and increased alcohol consumption are risk factors for the 
development of head and neck cancer 9 10 and head and neck cancer is more common in 
patients over 60 years of age. 
 
Quantifying stroke risk in patients is assisted by the use of several validated scores that are 
calculated based on risk factors. There are several risk prediction models available but, 
more recently, the Q-RISK2 and QSTROKE scores have been developed specifically to 
determine cardiovascular risk in UK populations. 11 12  The QSTROKE score was specifically 
designed to aid general practitioners in predicting a patient’s risk of developing a stroke.  A 
10-year risk of cardiovascular disease of 20% or greater is considered high risk, 10% to 
<20% is intermediate risk, and <10% low risk.13  Long-term survivors of head and neck 
cancer are often discharged to their primary care physicians after 5 years of follow-up, yet 
these patients may develop significant CAS and experience a neurological event after this 
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follow-up period.  General practitioners may use these recommended risk prediction models 
to risk-stratify these patients for future cardio- and cerebrovascular risk. 
 
Therefore, in order to assess whether patients with head and neck cancer treated with 
cervical RT are at increased risk of a cerebrovascular event primarily due to the radiotherapy 
or because these patients have other risk factors for atherosclerosis, this study was 
designed to (i) risk-stratify patients according to validated QRISK-2 and QSTROKE scores 
based on traditional risk factors for atherosclerosis, and (ii) compare the prevalence of CAS 
in irradiated and unirradiated carotid arteries. 
 
METHODS  
 
Head and neck cancer patients treated with radical RT to just one side of the neck prior to 
December 2009 were included.  Ethical approval was obtained from a regional Research 
Ethics Committee and the protocol for the study were reviewed by the Royal Marsden 
Committee for Clinical Research (CCR3687) and registered on clinicaltrials.gov 
(NCT02060643). 
 
Written informed consent was obtained from each participant and medication history and co-
morbidities were recorded.  Blood pressure, height and weight (to determine body mass 
index) were measured and electrocardiogram (ECG) was performed.  Blood samples were 
taken for haemoglobin, plasma glucose, lipid profile, renal and liver profile.  
 
QRISK-2 and QSTROKE 
The QRISK-2 (2014) and Q-STROKE (2014) scores were calculated using online calculators 
(www.qrisk.org and www.qstroke.org, respectively) to determine each patient’s 10-year risk 
of cardiovascular and cerebrovascular disease, respectively.  Details of each patient’s age, 
sex, race, co-morbidities, medication, systolic blood pressure, body mass index and 
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cholesterol to high-density lipoprotein (HDL) ratio were inputted into each calculator to 
determine a percentage 10-year risk.  
 
Ultrasound studies 
Carotid ultrasonography was performed for all participants using a high-resolution B-mode 
ultrasound system (Vivid-7; General Electric Healthcare, Chalfont, Bucks, UK) equipped with 
a broadband linear array (3-11 MHz) transducer.  All scans were performed by cardiologists 
who were blinded to the patient’s prior history including the laterality of RT.  ECG monitoring 
was performed continuously throughout the scan and arterial blood pressure was recorded 
using an automated sphygmomanometer.   
 
Segments of the CCA – proximal, mid, distal, and bifurcation, and the proximal portion of the 
internal carotid (ICA) and external carotid arteries (ECA) on both sides of the neck were 
examined with the patient supine on an examination couch.  The carotid waveforms, peak 
systolic (PSV) and end-diastolic velocities (EDV) were assessed online and recorded for the 
internal carotid artery and spectral measurements taken with a Doppler angle of 55 to 65 
degrees.  Four-beat video loops (long-axis and short-axis) of each segment of the CCA and 
the internal and external branches were stored for offline analysis.   
 
ICA stenosis 
The diagnostic criteria for ICA stenosis were based on PSV and EDV as well as ICA/CCA 
ratios.  Standard criteria for measuring ICA stenosis were used,14 and assessments were 
performed offline. 
 
The degree of stenosis is classified as follows:  Mild stenosis: 0 to 29%; Moderate stenosis: 
30% to 69%; Severe stenosis: 70% to 99%; Total occlusion: >99%. 
 
Plaque definition and non-ICA stenosis 
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Plaque was defined using the Mannheim consensus: a focal structure encroaching into the 
arterial lumen by >0.5 mm, a distinct area of IMT >50% greater than the adjacent wall or 
>1.5 mm in thickness.15  The percentage stenosis was calculated offline using the NASCET 
method, and is defined as the diameter of the normal lumen distal (A) to the stenosis minus 
the residual lumen at the site of stenosis (B) divided by A multiplied by 100 (Figure 2).16  For 
non-ICA plaques, the percentage stenosis was calculated only.  The number and location of 
plaques on each side of the neck was recorded.  For arteries with multiple discrete plaques, 
each plaque was graded separately. 
 
We looked at the effect of surgery on the prevalence of CAS by considering the unirradiated 
side of the neck and comparing the number of plaques in those treated with neck dissection 
to those that did not have a neck dissection.  A previous study reported that more patients 
had stenosis if they had had a neck dissection compared to those treated with RT alone.17  
This was an unexpected finding, as increased prevalence of carotid artery stenosis following 
surgery alone has not been observed.18  
 
Statistical Considerations 
Sample size 
Sample size calculation was based on the results from a previously published retrospective 
study by Dorresteijn et al,19 which looked at the difference in carotid intima medial thickness 
between irradiated (mean 1.13 mm) and unirradiated (mean 0.83 mm) carotid arteries.  With 
a significance level (α) of 0.05 and 80% power, the sample size required was 45 (using a 
paired t test with mean difference of 0.3 and standard deviation (SD) of 0.7).  Therefore, 50 
patients were recruited over an 18 month period to account for poor ultrasound windows that 
may limit image acquisition in a proportion of patients.  Although the calculation of the 
sample size for this current study was based on a different endpoint (CIMT), a study by 
Brown et al calculated a sample size of 40 patients would be required to show a difference in 
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stenosis using internal matched controls.17  Therefore, it is unlikely that our study is 
underpowered to show a difference. 
 
Statistical analysis 
Patient characteristics were summarised using descriptive statistics.  Quantitative variables 
were expressed as means (+/- standard deviations) and medians (including ranges) and 
qualitative variables were expressed as frequencies and percentages.  The use of risk-
modifying therapy was summarised in tabular form as whole numbers of each type of 
therapy and percentage of total patients in that group.  The prevalence of carotid stenosis in 
both irradiated and unirradiated carotid arteries was summarised as a percentage.  Degree 
of carotid stenosis on both sides of the neck was displayed in tabular form.  Differences in 
prevalence and degree of stenosis between the two sides of the neck were compared using 
the Chi-squared test.  The effect of surgery on the prevalence of carotid artery stenosis and 
the total number of plaques on the irradiated side was calculated using the chi-squared test 
and Mann Whitney test, respectively.  The prevalence of plaques in patient treated >5 years 
previously versus those treated <5 years previously was compared using the Mann Whitney 
test. 
 
All statistical tests were considered two-tailed with significant difference at the p<0.05 level.  
Statistical analyses were undertaken using Stats Direct Medical Statistics and Graphpad 
Prism 6 statistical packages. 
 
RESULTS 
 
Patient demographics 
 
Between January 2012 and June 2013, 50 patients were recruited in the study. One patient 
declined blood tests due to poor venous access. Demographic characteristics and risk 
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factors for atherosclerosis are summarised in table 1. Thirty-four patients (68%) had at least 
one risk factor for atherosclerosis.  More than half of the patients (58%) received 60 Gy to 
the neck and 68% of patients were treated with neck dissection as well as radiotherapy.  
Almost half of patients (46%) received platinum-based induction and/or concomitant 
chemotherapy. 
 
Radiation dose to carotid artery 
 
Fourteen patients (28%) had radiotherapy to the hemi-neck with a uniform dose prescribed 
to the hemi-neck.  The remaining 36 patients (72%) were treated with a wedged-pair 
(anterior and posterior radiotherapy beams to treat the ipsilateral hemi-oropharynx or parotid 
bed)  and matched hemi-neck field (anterior and posterior radiotherapy beams to cover the 
ipsilateral lower neck nodes below the hyoid bone cranially down to the clavicle caudally) 
(see figure 1).  The mean (standard deviation (SD)) maximum dose to the irradiated artery 
was 53 (13) Gy and 1.9 (3.7) Gy to the unirradiated side. 
 
QRISK-2 and QSTROKE scores 
 
The median QRISK-2 score was 10% (IQR 4.4-15%) and the median QSTROKE score was 
3.4% (IQR 1.4-5.3%).  QRISK-2 and QTROKE risk stratification are displayed in Figures 3 
and 4.  For the QRISK-2 score, the majority of patients are classified as low- or intermediate, 
with fewer than 5% in the high-risk category.  For the QSTROKE score, no patient was 
classified as high-risk and fewer than 5% were classified as intermediate-risk. 
 
Carotid artery stenosis 
 
Of the 50 patients who underwent carotid ultrasonography, 38 patients (76%) had CAS in 
one or both arteries.  Thirty-seven patients (74%) had carotid artery stenosis in the irradiated 
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artery and only one patient had plaque on the unirradiated side alone.  There was a 
significant difference in the number of irradiated arteries with stenosis (N=37) compared to 
the number of unirradiated arteries with stenosis (N=16) (p<0.0001).  Two patients with 
severe stenosis had extensive plaque throughout the CCA and were subsequently referred 
for vascular assessment.  
 
In total, 87 plaques were identified.  There was a significantly greater number of plaques on 
the irradiated artery compared to the unirradiated side (64/87) (73.6%) versus 23/87 
(26.4%), respectively) (p<0.001). The majority of documented stenoses were located in the 
carotid bulb (40/87 = 46%) and internal carotid artery (14/87 = 16.1%), with the rest located 
in the proximal, mid or distal CCA or ECA.  Table 2 demonstrates the number and degree of 
stenoses in the irradiated and unirradiated artery.  On the irradiated side, there was no 
difference in the prevalence of plaque (presence of plaque = yes or no) in those treated 
more than 5 years previously (17/24 patients = 70.8%) compared to those treated fewer than 
5 years previously (19/26 patients = 73.1%) (p>0.99). 
 
Effect of surgery on carotid artery stenosis 
 
On the irradiated side, there was no difference in the degree of stenosis in those patients 
who were treated with a neck dissection and radiotherapy compared to those who did not 
have a neck dissection (p=0.46) (Figure 5).  There was also no significant difference in the 
total number of plaques in those treated with both surgery and radiotherapy compared to 
those who did not have surgery (P=0.70). 
 
DISCUSSION 
 
This study demonstrated greater prevalence of CAS in irradiated carotid arteries in a cohort 
of patients with low- or intermediate-risk scores for cardiovascular and cerebrovascular 
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disease based on traditional risk factors for atherosclerosis.  No patient had cardiac RT 
because all of the tumours were located in the head and neck region above the clavicles.  
Cardiovascular risk was quantified to demonstrate risk prediction from traditional risk factors 
for atherosclerosis as 68% of patients had at least one risk factor.  It is still unclear how 
traditional vascular risk factors for atherosclerosis affect this process after RT.  Our study 
demonstrated no effect of surgery on ipsilateral CAS; a finding which has been previously 
reported.18  It has been suggested that radiation-induced damage is less likely to be affected 
by these factors.4  The degree of plaque on both sides of the neck seems out of proportion 
with the risk prediction for the cohort.  The QSTROKE score did not categorize any patient 
as being high-risk and only 2.5% as intermediate-risk. This suggests that established 
atherosclerosis (CAS) due to RT is independent of traditional risk factors and does not fit 
into a standard risk prediction model.  It is also clear that these risk prediction models cannot 
be applied in this setting and clinicians should be aware of the increased risk following RT, 
particularly after patients have been discharged from specialist follow-up (usually after 5 
years) to the primary care setting.  Indeed, some researches have suggested regular 
screening for CAS in long-term survivors following RT to the neck.17 20 
 
We have demonstrated that most plaques in irradiated arteries develop in the bulb.  
Seventy-two percent of patients were treated with a wedged-pair and matched hemi-neck 
technique, with the match-line just cranial to the carotid bulb.  As the wedged-pair fields 
would have been prescribed to a higher dose (65 or 60 Gy) than the hemi-neck fields (60 or 
50 Gy), there may have been resultant hotspots at the level of the bulb and consequent 
higher RT doses in this region.  This may be further investigated with modern dosimetric 
techniques in a prospective setting.  This study also demonstrated that surgery does not 
appear to have an effect on the prevalence of CAS and suggests that combined modality 
treatment does not have an additive effect on vascular tissue compared to surgery or RT 
alone. 
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It is unclear why there were a considerable number of plaques on the unirradiated artery.  
Forty-six percent of patients were treated with chemotherapy in addition to radiotherapy. 
Vascular damage following platinum-based chemotherapy has been reported in patients 
treated with chemotherapy for testicular cancers,21 a cancer primarily of young, healthy 
males with no atherosclerotic risk factors and often cured by chemotherapy alone i.e. without 
the possible confounders of surgery or RT.   This may explain the considerable number of 
plaques on the unirradiated artery.  It is important to remember, however, that chemotherapy 
effects would be expected to be equal on both sides of the neck and, therefore, would not 
explain the difference in the number and grading of plaques between the two sides of the 
neck.  It is also possible that radiotherapy-induced damage to endothelial cells, with 
subsequent release of certain growth factors such as platelet-derived growth factor (PDGF) 
and basic fibroblast growth factor (bFGF), as well as cytokines,22 may have a systemic effect 
on vessels remote to the site of injury, but this requires further investigation. 
The long latent interval from RT to the development of established atherosclerosis and 
neurological sequelae hampers investigation of this process and, importantly, the conduct of 
interventional clinical studies.  Therefore, as in spontaneous atherosclerosis, early relevant 
biomarkers of radiation-induced atherosclerosis are required. There has been a lot of 
interest in recent decades in arterial wall thickening (carotid intima medial thickness (CIMT), 
a validated surrogate biomarker for cardiovascular and cerebrovascular events in 
spontaneous atherosclerosis) as an imaging biomarker of radiation-induced atherosclerosis. 
7  Current evidence suggests increased CIMT may be detected as early as 6-12 months 
after RT, 23 24 making this an attractive surrogate biomarker for prediction of stroke risk. 
 
We have shown no difference in the prevalence of plaques or the total number of plaques on 
the irradiated side in those patients treated more than 5 years previously compared to those 
treated fewer than 5 years previously.  This is in contrast to previously reported studies 
which showed an increased prevalence after 15 years 17 and after 5 years.20  Both studies 
had a longer median interval from RT of 90 months and 72 months, respectively, compared 
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to 53 months in our current study.  It is, therefore, possible that, with longer follow-up, a 
significant difference in carotid stenosis prevalence may be seen.  Our study does suggest, 
however, that an interval from RT of less than 5 years is unlikely to result in a significant 
increase in the prevalence of stenosis.  Therefore, surrogate biomarkers for radiation-
induced atherosclerosis should consider the likely time interval from RT to development of 
neurological sequelae in the development of risk prediction models in this setting, with one 
study reporting a median interval to cerebrovascular events of 10.2 years. 25 
 
CONCLUSION 
 
This study demonstrated a significantly higher prevalence of CAS in irradiated arteries, in a 
cohort that would be considered low- or intermediate-risk based on a traditional risk 
prediction model.  This supports the suggestion that traditional vascular risk factors do not 
play a role in radiation-induced carotid atherosclerosis.  Clinicians should be aware that 
traditional risk prediction models for stroke may under-estimate the risk in these patients.   
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Table 1. Patient demographics and risk factors for carotid atherosclerosis  
 
Demographic characteristics/risk factors Number (%) (N=50) 
Female 16 (32%) 
Age, median (interquartile range (IQR)) 58 (50 – 62) 
Histology Squamous 39 (78%) 
Non-squamous  11 (22%) 
Primary site Tonsil 41 (82%) 
 Parotid 9   (18%) 
Tumour Stage  0 7 (14%) 
1 22 (44%) 
2 17 (34%) 
3 1 (2%) 
4 3 (6%) 
Nodal Status 0 12 (24%) 
1 10 (20%) 
2 28 (56%) 
Neck Dissection 33 (66%) 
Induction Chemotherapy 7 (14%) 
Concomitant Chemotherapy 23 (46%) 
RT dose to neck 
(Gy) 
50 Gy 20 (40%) 
60 Gy 29 (58%) 
 63 Gy 1 (2%) 
Interval since RT (months), median (IQR) 53.9 (42.3- 90.5) 
Risk Factors Diabetes 4 (8%) 
Hypertension 14 (28%) 
Dyslipidaemia 11 (22%) 
Smoker/Ex-Smoker 27 (54%) 
Body Mass Index (kg/m2), median (IQR) 26.5 (23.2 – 28.4) 
Medication Aspirin 13 (26%) 
ACE Inhibitors 5 (10%) 
5-HMG Co-A reductase 
Inhibitor 
13 (26%) 
Total Cholesterol , median (IQR) 5.1 (4.6 - 5.8) 
Low Density Lipoproteins, median (IQR) 3.3 (2.6 - 3.7) 
High Density Lipoproteins, median (IQR) 1.4 (1.2 – 1.7) 
 
 
 
 
 
 
 
 18 
Table 2.  Grading of stenosis in irradiated and unirradiated arteries (on the irradiated side, 
37 patients had a total of 64 plaques, and 16 unirradiated arteries had a total of 23 plaques) 
(p<0.001) 
CAS (N=87 
plaques) 
Irradiated carotid 
artery  
Number (%) 
Unirradiated 
carotid artery 
Number (%) 
Mild 40 (46) 15(17.2) 
Moderate 21 (24.1) 8 (9.2) 
Severe 3 (3.5) 0 
Total 
occlusion 
0 0 
Total 64 (73.6) 23 (26.4) 
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Figure legends 
 
Figure 1.  Typical radiation treatment plan for a left tonsil cancer, showing dose colourwash 
(colours joining regions of the same dose) to the primary tumour treated with a wedged pair 
technique (A) and a matched lower neck field (B) to cover ipsilateral neck lymph node 
groups.  The ipsilateral (left) common carotid artery (and some of its branches) is included in 
the radiation fields. 
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Figure 2.  Calculation of percentage carotid artery stenosis in a patient with plaque 
using the NASCET method 
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Figure 3.  Risk stratification using QRISK-2 score 
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Figure 4.  Risk stratification using QSTROKE score 
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Figure 5.  Number and degree of plaques on the irradiated side in patients who had surgery 
versus those who did not have surgery (p=0.70) 
 
 
